Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials.
American Journal of Geriatric Psychiatry（2019）
Key words
Humans,brexpiprazole,clinical trial,double-blind method,Alzheimer disease,agitation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined